维普中文期刊产品整合服务
62篇 您的检索式:作者名="Mlineritsch"
    题名 作者 年代 出处 被引量
1Exemestane as primary systemic treatment for hormone receptor positive post- menopausal breast cancer patients: A phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG- 17) 显示文摘Mlineritsch B Tausch C Singer C 2008Breast Cancer Res Treat2008,112,1:1
2Endocrine therapy plus zoledronic acid in premenopausal breast cancer显示文摘Gnant M Mlineritsch B Schippinger W 2009N Engl J Med2009,360,7:1
3Endocrine therapy plus zoledronic acid in premenopausal breast cancer 显示文摘Gnant M Mlineritsch B Sehippinger W 2009N Engl J Med2009,360,7:1
4Endocrine therapy plus zoledronic acid in premenopausal breast cancer显示文摘Gnant M Mlineritsch B Schippinger W 2009N Engl J Med2009,360,7:1
5Zoledronic acid for adjuvant use in patients with breast cancer 显示文摘Ressler S Mlineritsch B Greil R 2011Expert Rev Anticancer Ther2011,11,3:1
6Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial显示文摘Michael Gnant Brigitte Mlineritsch Herbert Stoeger Gero Luschin-Ebengreuth Dietmar Heck Christian Menzel Raimund Jakesz Michael Seifert Michael Hubalek Gunda Pristauz Thomas Bauernhofer Holger Eidtmann Wolfgang Eiermann Guenther Steger Werner Kwasny Peter 2011Lancet Oncology2011,,7:1
7Adjuvant endocrine therapy plus zoledron- ic acid in premenopausal women with ear- ly-stage breast cancer:62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoeger H 2011Lancet Oncol2011,12,7:1
8Adjuvant ovarian suppression combined with tamoxi{en or anastrozole, alone or in combination with zoledronic acid,in premenopausal women with hormone-responsive, stage Ⅰ and Ⅱ breast cancer:First efficacy results from ABCSG-12显示文摘Gnant M Mlineritsch B Schippinger W 2008Clin Oncol2008,26,20:1
9Endocrine therapy plus zoledronic acid in premenopausal breast cancer 显示文摘Gnant M Mlineritsch B Schippinger W 2009N Engl J Med2009,360,7:1
10Mature results from ABCSG-12: adjuvant ovarian suppression combined with tamox- ifen or anastrozole, alone or in combination with zoledronie acid, in premenopansal women with endocrine-responsive early breast cancer显示文摘Gnant M Mlineritsch B Stoeger H 2010J ClinOncol2010,,:1
11Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoeger H 2011Lancet Oncol2011,12,7:1
12Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer:62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoegcr H 2011Lancet Oncol2011,12,7:1
13Austrian Breast and Colorectal Cancer Study Group (ABCSG):Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy显示文摘Gnant M Mlineritsch B Luschin-Ebengreuth G 2008Lancet Oncol2008,9,9:1
14Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early- stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial 显示文摘Gnant M Mlineritsch B Stoeger H 2011Lancet Oncol2011,12,7:1
15Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial显示文摘Michael Gnant Brigitte Mlineritsch Herbert Stoeger Gero Luschin-Ebengreuth Dietmar Heck Christian Menzel Raimund Jakesz Michael Seifert Michael Hubalek Gunda Pristauz Thomas Bauernhofer Holger Eidtmann Wolfgang Eiermann Guenther Steger Werner Kwasny Peter 2011Lancet Oncology2011,,7:1
16Adjuvant endocrine therapy plus zoledronic acid inpremenopausal women with early - stage breast canc-er: 5 - year follow - up of the ABCSG - 12 bone -mineral density substudy 显示文摘Gnant M Mlineritsch B Luschin - Ebengreuth G etal 2008Lancet Oncol2008,9,9:1
17Endocrine therapy plus zoledronic acid in premenopausal breast cancer显示文摘Gnant M Mlineritsch B Schippinger W 2009N Engl J Med2009,360,7:1
18Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer:62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoeger H 0,,07:1
19Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with ear- ly-stage breast cancer:62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoeger H 2011Lancet Oncol2011,12,7:1
20Adjuvant en- docrine therapy plus zoledronie acid in premenopausal women with early-stage breast cancer:62-month follow-up from the ABCSG-12 randomised trial显示文摘Gnant M Mlineritsch B Stoeger H 2011Lancet Oncol2011,12,7:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费